Cargando…

The Pros and Cons of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing Pulmonaria officinalis L. Extract: the Evidence from an In Vitro Study on Staphylococcus aureus CF Clinical Isolates

The justification for the use of herbal supplements with Pulmonaria officinalis L. extract (POE) in the case of staphylococcal lung colonization/infections characteristic for cystic fibrosis (CF), was examined in vitro. The impact of POE phenolic-rich fraction on the virulence attributes of CF-assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadowska, Beata, Wójcik, Urszula, Krzyżanowska-Kowalczyk, Justyna, Kowalczyk, Mariusz, Stochmal, Anna, Rywaniak, Joanna, Burzyńska, Julia, Różalska, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471470/ https://www.ncbi.nlm.nih.gov/pubmed/30909529 http://dx.doi.org/10.3390/molecules24061151

Ejemplares similares

Pulmonaria obscura and Pulmonaria officinalis Extracts as Mitigators of Peroxynitrite-Induced Oxidative Stress and Cyclooxygenase-2 Inhibitors–In Vitro and In Silico Studies
por: Krzyżanowska-Kowalczyk, Justyna, et al.
Publicado: (2021)

Novel Phenolic Constituents of Pulmonaria officinalis L. LC-MS/MS Comparison of Spring and Autumn Metabolite Profiles
por: Krzyżanowska-Kowalczyk, Justyna, et al.
Publicado: (2018)

Evaluation of tests to predict metallo-β-lactamase in cystic fibrosis (CF) and non-(CF) Pseudomonas
por: Perez, Leandro Reus Rodrigues, et al.
Publicado: (2014)

Phenolic and Nonpolar Fractions of Elaeagnus rhamnoides (L.) A. Nelson Extracts as Virulence Modulators—In Vitro Study on Bacteria, Fungi, and Epithelial Cells
por: Różalska, Barbara, et al.
Publicado: (2018)

Improving the care of patients with cystic fibrosis (CF)
por: Khan, Ahsan Aftab, et al.
Publicado: (2017)

Phenolic and Non-Polar Fractions of the Extracts from Fruits, Leaves, and Twigs of Elaeagnus rhamnoides (L.) A. Nelson—The Implications for Human Barrier Cells
por: Sadowska, Beata, et al.
Publicado: (2020)

Evaluation of Antimicrobial, Antioxidant, and Cytotoxic Activity of Phenolic Preparations of Diverse Composition, Obtained from Elaeagnus rhamnoides (L.) A. Nelson Leaf and Twig Extracts
por: Stochmal, Anna, et al.
Publicado: (2021)

Staphylococcus aureus—A Known Opponent against Host Defense Mechanisms and Vaccine Development—Do We Still Have a Chance to Win?
por: Wójcik-Bojek, Urszula, et al.
Publicado: (2022)

Theoretical insight into OH- and Cl-initiated oxidation of CF(3)OCH(CF(3))(2) and CF(3)OCF(2)CF(2)H & fate of CF(3)OC(X•)(CF(3))(2) and CF(3)OCF(2)CF(2)X• radicals (X=O, O(2))
por: Bai, Feng-Yang, et al.
Publicado: (2017)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

Sticta Pulmonaria
por: Smith, C. Carleton
Publicado: (1889)

Antioxidant activity, acetylcholinesterase and tyrosinase inhibitory potential of Pulmonaria officinalis and Centarium umbellatum extracts
por: Neagu, Elena, et al.
Publicado: (2018)

Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis
por: Schäfer, Jürgen, et al.
Publicado: (2018)

68 Respiratory viral detection in children with cystic fibrosis (CF)
por: Tješić-Drinković, I., et al.
Publicado: (2015)

492: CF innate immune defect affects CF intestinal microbiota
por: Scull, C., et al.
Publicado: (2021)

Trifluoromethyl Thianthrenium Triflate: A Readily Available Trifluoromethylating Reagent with Formal CF(3)(+), CF(3)(•), and CF(3)(–) Reactivity
por: Jia, Hao, et al.
Publicado: (2021)

Gene therapy for CF.
por: Eubanks, M
Publicado: (2001)

Rehabilitation Programs for Cystic Fibrosis – View from a CF Center
por: Griese, M, et al.
Publicado: (2010)

Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas
por: Evans, Ieuan E. S., et al.
Publicado: (2023)

Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology
por: Barone, Simona, et al.
Publicado: (2022)

SERCA2 Regulates Non-CF and CF Airway Epithelial Cell Response to Ozone
por: Ahmad, Shama, et al.
Publicado: (2011)

Manifestation of clustering in the $^{252}Cf(sf)$ and $^{249}Cf(n_{th},f)$ reactions
por: Pyatkov, Yu V, et al.
Publicado: (1996)

Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin
por: Filipic, Brankica, et al.
Publicado: (2017)

General, Practical and Selective Oxidation Protocol for CF(3)S into CF(3)S(O) Group
por: Sokolenko, Liubov V., et al.
Publicado: (2019)

Access to N−CF(3) Formamides by Reduction of N−CF(3) Carbamoyl Fluorides
por: Zivkovic, Filip G., et al.
Publicado: (2022)

Improving health literacy of antibiotic use in people with cystic fibrosis (CF)—comparison of the readability of patient information leaflets (PILs) from the EU, USA and UK of 23 CF-related antibiotics used in the treatment of CF respiratory infections
por: Tang, Ka Wah Kelly, et al.
Publicado: (2023)

An In Vitro Study of the Effect of Viburnum opulus Extracts on Key Processes in the Development of Staphylococcal Infections
por: Wójcik-Bojek, Urszula, et al.
Publicado: (2021)

Two cases of non-cystic fibrosis (CF) bronchiectasis with allergic bronchopulmonary aspergillosis
por: De, Hriday, et al.
Publicado: (2016)

1481. Clinical Outcomes of Escherichia coli Infections in Cystic Fibrosis (CF) Patients
por: Edwards, Brett, et al.
Publicado: (2018)

Oral Hygiene and Periodontal Treatment Needs in Adult Patients with Cystic Fibrosis (CF)
por: Hildebrandt, Tomasz, et al.
Publicado: (2022)

Professor C.F. Powell
Publicado: (1969)

Class 1 CF Mutations
por: Wilschanski, Michael
Publicado: (2012)

Psychological Impact of NBS for CF
por: Chudleigh, Jane, et al.
Publicado: (2020)

Unusual presentation of CF in an infant
por: Portillo Miño, José Dario, et al.
Publicado: (2020)

Comparisons of resistance of CF and Non-CF pathogens to Hydrogen Peroxide and Hypochlorous Acid Oxidants In Vitro
por: Bonvillain, Ryan W, et al.
Publicado: (2011)

The Role of Receptor for Advanced Glycation End Products in Airway Inflammation in CF and CF related Diabetes
por: Mulrennan, Siobhain, et al.
Publicado: (2015)

A CF patient with progressive proteinuric renal disease: a CF-specific nodular glomerulosclerosis?
por: O’Connell, Oisin, et al.
Publicado: (2010)

Comparative effects of CFTR modulators on phagocytic, metabolic and inflammatory profiles of CF and nonCF macrophages
por: Aridgides, Daniel S., et al.
Publicado: (2023)

Among-Population Variation in Microbial Community Structure in the Floral Nectar of the Bee-Pollinated Forest Herb Pulmonaria officinalis L
por: Jacquemyn, Hans, et al.
Publicado: (2013)

Differences in fine-scale spatial genetic structure across the distribution range of the distylous forest herb Pulmonaria officinalis (Boraginaceae)
por: Meeus, Sofie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4pqt07iq431g0njfjjmavq1m8r